Glenview Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,307,068
Closed -$9.11M 47
2024
Q2
$9.11M Buy
+1,307,068
New +$9.89M 0.18% 41
2023
Q3
Sell
-1,766,395
Closed -$14.1M 53
2023
Q2
$14.1M Buy
+1,766,395
New +$13M 0.32% 35
2023
Q1
Sell
-1,500,000
Closed -$9.42M 56
2022
Q4
$9.42M Buy
+1,500,000
New +$10.5M 0.21% 44
2022
Q2
Sell
-9,256,661
Closed -$212M 57
2022
Q1
$212M Sell
9,256,661
-3,245,486
-26% -$79.3M 4.28% 7
2021
Q4
$345M Sell
12,502,147
-3,147,096
-20% -$84.2M 7.36% 3
2021
Q3
$436M Sell
15,649,243
-688,306
-4% -$19.5M 7.9% 2
2021
Q2
$479M Buy
16,337,549
+724,459
+5% +$21.9M 7.92% 2
2021
Q1
$496M Sell
15,613,090
-820,929
-5% -$24.1M 8.4% 2
2020
Q4
$342M Buy
16,434,019
+1,476,311
+10% +$27.5M 7.84% 2
2020
Q3
$232M Sell
14,957,708
-686,420
-4% -$11.8M 7.3% 3
2020
Q2
$286M Sell
15,644,128
-972,880
-6% -$17.1M 7.89% 3
2020
Q1
$258M Hold
16,617,008
7% 4
2019
Q4
$497M Buy
16,617,008
+2,806,494
+20% +$73M 4.35% 9
2019
Q3
$302M Buy
13,810,514
+4,095,270
+42% +$93.7M 3.17% 11
2019
Q2
$245M Buy
9,715,244
+400,000
+4% +$9.5M 2.22% 16
2019
Q1
$230M Buy
9,315,244
+2,724,936
+41% +$65.1M 2.05% 18
2018
Q4
$122M Buy
6,590,308
+3,060,703
+87% +$72.8M 1.18% 23
2018
Q3
$90.6M Buy
+3,529,605
New +$80.8M 0.58% 46

Other funds holding BHC

Glenview Capital Management's BHC Position: Q3 2024 in Review

Glenview Capital Management sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 1,307,068 shares — an estimated $9.11M sold.

Glenview Capital Management first reported a position in BHC in Q3 2018 and held it in 18 quarters. The position peaked at $497M in Q4 2019. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Glenview Capital Management reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • Glenview Capital Management sold 1,307,068 Bausch Health shares in Q3 2024, an estimated $9.11M.
  • Glenview Capital Management first reported a position in Bausch Health in Q3 2018 and held it in 18 quarters.
  • Glenview Capital Management's Bausch Health position peaked at $497M in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Glenview Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.